The pharmaceutical community is buzzing about the new drug, a dual-action therapy showing remarkable outcomes in early trials . This new compound, a GLP-1 receptor agonist alongside a GIP molecule , appears to substantially decrease body weight and enhance metabolic health . Researchers are indicating that it could offer a real breakthrough for … Read More